Fate Therapeutics (FATE) Non-Current Debt (2012 - 2019)

Fate Therapeutics has reported Non-Current Debt for 8 years, with the latest figure at $9.5 million in Q2 2019.

• For the quarter ending Q2 2019, Non-Current Debt fell 26.23% year-over-year to $9.5 million; the trailing twelve-month figure through Jun 2019 stood at $9.5 million (down 26.23% YoY), and the FY2018 full-year result was $12.4 million, down 15.95% from the prior year.
• Non-Current Debt for Q2 2019 stood at $9.5 million, down from $11.0 million in the prior quarter.
• The five-year high for Non-Current Debt was $16.4 million in Q1 2015, with the low at $1.1 million in Q1 2017.
• Historically, Non-Current Debt has averaged $10.3 million across 5 years, with a median of $11.3 million in 2018.
• Annual changes were most pronounced in 2017 — Non-Current Debt plunged 87.57% — and 2018, when it surged 1201.48%.
• Fate Therapeutics' Non-Current Debt stood at $10.7 million in 2015, then plunged by 76.6% to $2.5 million in 2016, then surged by 492.08% to $14.8 million in 2017, then decreased by 15.95% to $12.4 million in 2018, then dropped by 23.92% to $9.5 million in 2019.
• The last three Non-Current Debt figures came in at $9.5 million (Q2 2019), $11.0 million (Q1 2019), and $12.4 million (Q4 2018), per Business Quant data.